<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00595894</url>
  </required_header>
  <id_info>
    <org_study_id>028-03-ET</org_study_id>
    <secondary_id>5K23AR050004-04</secondary_id>
    <nct_id>NCT00595894</nct_id>
  </id_info>
  <brief_title>Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans</brief_title>
  <official_title>RA Comorbidity: Bone Health in Men and African Americans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the proposed study is to assess bone health and determinants of bone health
      among select subpopulations of rheumatoid arthritis patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall hypothesis of this study is that osteopenia and/or osteoporosis are common among
      African Americans and men with rheumatoid arthritis and there are identifiable genetic and
      environmental factors contributing to the pathogenesis of bone loss in these groups.

      The Specific Aims of the study are to:

        1. Determine baseline hip and lumbar spine bone density (BMD) values and
           osteopenia/osteoporosis prevalence among African American men and women with early RA
           and among male veterans with established RA.

        2. Identify environmental factors and candidate alleles, which confer increased risk of
           reduced baseline BMD loss over time among African American men and women with early RA
           and among male veterans with established RA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2004</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bone mineral density</measure>
    <time_frame>baseline and at 5 years disease</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1745</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>CLEAR enrollees include African American patients with early rheumatoid arthritis, as defined using ACR criteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>VARA enrollees will include male veterans with established RA diagnosed using ACR criteria</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Baseline sera and DNA collected
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        CLEAR enroll African American RA patients from 4 core academic centers in the Southeast
        U.S. VARA enroll RA patientss from participating VA medical centers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of rheumatoid arthritis per ACR guidelines

        Exclusion Criteria:

          -  Patients with diagnosis &gt; 2yrs (CLEAR study)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ted R Mikuls, MD, MSPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nebraska</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Omaha VA Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Omaha Veterans Affairs Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.nih.gov</url>
    <description>National Institute of Health</description>
  </link>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2008</study_first_submitted>
  <study_first_submitted_qc>January 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2008</study_first_posted>
  <last_update_submitted>June 18, 2013</last_update_submitted>
  <last_update_submitted_qc>June 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 19, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nebraska</investigator_affiliation>
    <investigator_full_name>Ted Mikuls, MD MSPH</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>rheumatoid arthritis</keyword>
  <keyword>African Americans</keyword>
  <keyword>osteopenia</keyword>
  <keyword>osteoporosis</keyword>
  <keyword>bone mineral density</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

